This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Seikagaku Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Toshihiko Sawada: Innovator in Sulfotransferase Inhibitors
Introduction
Toshihiko Sawada is a notable inventor based in Kitashitara-gun, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of sulfotransferase inhibitors. His work has implications for various therapeutic applications.
Latest Patents
Toshihiko Sawada holds a patent for sulfotransferase inhibitors, specifically a galactosamine derivative represented by a complex formula. This invention includes various components where R, R, and R can represent different chemical groups, contributing to the efficacy of the inhibitor. The patent highlights the innovative approach to targeting sulfotransferase enzymes, which play a crucial role in cellular processes.
Career Highlights
Sawada is associated with Seikagaku Corporation, a company known for its focus on glycoscience and biopharmaceuticals. His work at the corporation has allowed him to explore and develop new therapeutic agents that can potentially improve patient outcomes.
Collaborations
Toshihiko Sawada has collaborated with esteemed colleagues such as Osami Habuchi and Hirofumi Nakano. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Toshihiko Sawada's contributions to the field of sulfotransferase inhibitors exemplify the importance of innovation in biochemistry. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile